New pill tested to help kids focus in school
Disease control
Completed
This study tested a new once-daily pill called CTx-1301 for treating ADHD in children and teenagers aged 6 to 17. Over 100 participants were randomly assigned to receive either the active drug or a placebo (a pill with no medicine) for about 5 weeks to see if it safely improved A…
Phase: PHASE3 • Sponsor: Cingulate Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC